Global Bio Pharma Buffer Market Growth 2020-2025


Nov, 2020 | Report ID: 160849 | 163 | Pharmaceuticals and Healthcare

According to this study, over the next five years the Bio Pharma Buffer market will register a 7.5%% CAGR in terms of revenue, the global market size will reach $ 1031.3 million by 2025, from $ 773.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Bio Pharma Buffer business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Bio Pharma Buffer market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Bio Pharma Buffer, covering the supply chain analysis, impact assessment to the Bio Pharma Buffer market size growth rate in several scenarios, and the measures to be undertaken by Bio Pharma Buffer companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Phosphates Type

Acetates Type

TRIS Type

Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Research Institution

Pharmaceutical Industry

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Avantor

XZL BIO-TECHNOLOGY

Alfa Aesar (Thermo Fisher)

Lonza

Bio-Rad

Merck

Promega Corporation

BD

Hamilton Company

GE Healthcare

SRL

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Bio Pharma Buffer consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Bio Pharma Buffer market by identifying its various subsegments.

Focuses on the key global Bio Pharma Buffer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Bio Pharma Buffer with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Bio Pharma Buffer submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bio Pharma Buffer Consumption 2015-2025

2.1.2 Bio Pharma Buffer Consumption CAGR by Region

2.2 Bio Pharma Buffer Segment by Type

2.2.1 Phosphates Type

2.2.2 Acetates Type

2.2.3 TRIS Type

2.2.4 Others

2.3 Bio Pharma Buffer Consumption by Type

2.3.1 Global Bio Pharma Buffer Consumption Market Share by Type (2015-2020)

2.3.2 Global Bio Pharma Buffer Revenue and Market Share by Type (2015-2020)

2.3.3 Global Bio Pharma Buffer Sale Price by Type (2015-2020)

2.4 Bio Pharma Buffer Segment by Application

2.4.1 Research Institution

2.4.2 Pharmaceutical Industry

2.4.3 Others

2.5 Bio Pharma Buffer Consumption by Application

2.5.1 Global Bio Pharma Buffer Consumption Market Share by Type (2015-2020)

2.5.2 Global Bio Pharma Buffer Value and Market Share by Type (2015-2020)

2.5.3 Global Bio Pharma Buffer Sale Price by Type (2015-2020)

3 Global Bio Pharma Buffer by Company

3.1 Global Bio Pharma Buffer Sales Market Share by Company

3.1.1 Global Bio Pharma Buffer Sales by Company (2018-2020)

3.1.2 Global Bio Pharma Buffer Sales Market Share by Company (2018-2020)

3.2 Global Bio Pharma Buffer Revenue Market Share by Company

3.2.1 Global Bio Pharma Buffer Revenue by Company (2018-2020)

3.2.2 Global Bio Pharma Buffer Revenue Market Share by Company (2018-2020)

3.3 Global Bio Pharma Buffer Sale Price by Company

3.4 Global Bio Pharma Buffer Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Bio Pharma Buffer Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Bio Pharma Buffer Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Bio Pharma Buffer by Regions

4.1 Bio Pharma Buffer by Regions

4.2 Americas Bio Pharma Buffer Consumption Growth

4.3 APAC Bio Pharma Buffer Consumption Growth

4.4 Europe Bio Pharma Buffer Consumption Growth

4.5 Middle East & Africa Bio Pharma Buffer Consumption Growth

5 Americas

5.1 Americas Bio Pharma Buffer Consumption by Countries

5.1.1 Americas Bio Pharma Buffer Consumption by Countries (2015-2020)

5.1.2 Americas Bio Pharma Buffer Value by Countries (2015-2020)

5.2 Americas Bio Pharma Buffer Consumption by Type

5.3 Americas Bio Pharma Buffer Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Bio Pharma Buffer Consumption by Regions

6.1.1 APAC Bio Pharma Buffer Consumption by Regions (2015-2020)

6.1.2 APAC Bio Pharma Buffer Value by Regions (2015-2020)

6.2 APAC Bio Pharma Buffer Consumption by Type

6.3 APAC Bio Pharma Buffer Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Bio Pharma Buffer by Countries

7.1.1 Europe Bio Pharma Buffer Consumption by Countries (2015-2020)

7.1.2 Europe Bio Pharma Buffer Value by Countries (2015-2020)

7.2 Europe Bio Pharma Buffer Consumption by Type

7.3 Europe Bio Pharma Buffer Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Bio Pharma Buffer by Countries

8.1.1 Middle East & Africa Bio Pharma Buffer Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Bio Pharma Buffer Value by Countries (2015-2020)

8.2 Middle East & Africa Bio Pharma Buffer Consumption by Type

8.3 Middle East & Africa Bio Pharma Buffer Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Bio Pharma Buffer Distributors

10.3 Bio Pharma Buffer Customer

11 Global Bio Pharma Buffer Market Forecast

11.1 Global Bio Pharma Buffer Consumption Forecast (2021-2025)

11.2 Global Bio Pharma Buffer Forecast by Regions

11.2.1 Global Bio Pharma Buffer Forecast by Regions (2021-2025)

11.2.2 Global Bio Pharma Buffer Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Bio Pharma Buffer Forecast by Type

11.8 Global Bio Pharma Buffer Forecast by Application

12 Key Players Analysis

12.1 Avantor

12.1.1 Company Information

12.1.2 Bio Pharma Buffer Product Offered

12.1.3 Avantor Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Avantor Latest Developments

12.2 XZL BIO-TECHNOLOGY

12.2.1 Company Information

12.2.2 Bio Pharma Buffer Product Offered

12.2.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 XZL BIO-TECHNOLOGY Latest Developments

12.3 Alfa Aesar (Thermo Fisher)

12.3.1 Company Information

12.3.2 Bio Pharma Buffer Product Offered

12.3.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Alfa Aesar (Thermo Fisher) Latest Developments

12.4 Lonza

12.4.1 Company Information

12.4.2 Bio Pharma Buffer Product Offered

12.4.3 Lonza Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Lonza Latest Developments

12.5 Bio-Rad

12.5.1 Company Information

12.5.2 Bio Pharma Buffer Product Offered

12.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Bio-Rad Latest Developments

12.6 Merck

12.6.1 Company Information

12.6.2 Bio Pharma Buffer Product Offered

12.6.3 Merck Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Merck Latest Developments

12.7 Promega Corporation

12.7.1 Company Information

12.7.2 Bio Pharma Buffer Product Offered

12.7.3 Promega Corporation Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Promega Corporation Latest Developments

12.8 BD

12.8.1 Company Information

12.8.2 Bio Pharma Buffer Product Offered

12.8.3 BD Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 BD Latest Developments

12.9 Hamilton Company

12.9.1 Company Information

12.9.2 Bio Pharma Buffer Product Offered

12.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Hamilton Company Latest Developments

12.10 GE Healthcare

12.10.1 Company Information

12.10.2 Bio Pharma Buffer Product Offered

12.10.3 GE Healthcare Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 GE Healthcare Latest Developments

12.11 SRL

12.11.1 Company Information

12.11.2 Bio Pharma Buffer Product Offered

12.11.3 SRL Bio Pharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 SRL Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Bio Pharma Buffer Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Phosphates Type

Table 5. Major Players of Acetates Type

Table 6. Major Players of TRIS Type

Table 7. Major Players of Others

Table 8. Global Consumption Sales by Type (2015-2020)

Table 9. Global Bio Pharma Buffer Consumption Market Share by Type (2015-2020)

Table 10. Global Bio Pharma Buffer Revenue by Type (2015-2020) ($ million)

Table 11. Global Bio Pharma Buffer Value Market Share by Type (2015-2020) ($ Millions)

Table 12. Global Bio Pharma Buffer Sale Price by Type (2015-2020)

Table 13. Global Consumption Sales by Application (2015-2020)

Table 14. Global Bio Pharma Buffer Consumption Market Share by Application (2015-2020)

Table 15. Global Bio Pharma Buffer Value by Application (2015-2020)

Table 16. Global Bio Pharma Buffer Value Market Share by Application (2015-2020)

Table 17. Global Bio Pharma Buffer Sale Price by Application (2015-2020)

Table 18. Global Bio Pharma Buffer Sales by Company (2017-2019) (kL)

Table 19. Global Bio Pharma Buffer Sales Market Share by Company (2017-2019)

Table 20. Global Bio Pharma Buffer Revenue by Company (2017-2019) ($ Millions)

Table 21. Global Bio Pharma Buffer Revenue Market Share by Company (2017-2019)

Table 22. Global Bio Pharma Buffer Sale Price by Company (2017-2019)

Table 23. Global Bio Pharma Buffer Manufacturing Base Distribution and Sales Area by Manufacturers

Table 24. Players Bio Pharma Buffer Products Offered

Table 25. Bio Pharma Buffer Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 26. Global Bio Pharma Buffer Consumption by Regions 2015-2020 (kL)

Table 27. Global Bio Pharma Buffer Consumption Market Share by Regions 2015-2020

Table 28. Global Bio Pharma Buffer Value by Regions 2015-2020 ($ Millions)

Table 29. Global Bio Pharma Buffer Value Market Share by Regions 2015-2020

Table 30. Americas Bio Pharma Buffer Consumption by Countries (2015-2020) (kL)

Table 31. Americas Bio Pharma Buffer Consumption Market Share by Countries (2015-2020)

Table 32. Americas Bio Pharma Buffer Value by Countries (2015-2020) ($ Millions)

Table 33. Americas Bio Pharma Buffer Value Market Share by Countries (2015-2020)

Table 34. Americas Bio Pharma Buffer Consumption by Type (2015-2020) (kL)

Table 35. Americas Bio Pharma Buffer Consumption Market Share by Type (2015-2020)

Table 36. Americas Bio Pharma Buffer Consumption by Application (2015-2020) (kL)

Table 37. Americas Bio Pharma Buffer Consumption Market Share by Application (2015-2020)

Table 38. APAC Bio Pharma Buffer Consumption by Countries (2015-2020) (kL)

Table 39. APAC Bio Pharma Buffer Consumption Market Share by Countries (2015-2020)

Table 40. APAC Bio Pharma Buffer Value by Regions (2015-2020) ($ Millions)

Table 41. APAC Bio Pharma Buffer Value Market Share by Regions (2015-2020)

Table 42. APAC Bio Pharma Buffer Consumption by Type (2015-2020) (kL)

Table 43. APAC Bio Pharma Buffer Consumption Market Share by Type (2015-2020)

Table 44. APAC Bio Pharma Buffer Consumption by Application (2015-2020) (kL)

Table 45. APAC Bio Pharma Buffer Consumption Market Share by Application (2015-2020)

Table 46. Europe Bio Pharma Buffer Consumption by Countries (2015-2020) (kL)

Table 47. Europe Bio Pharma Buffer Consumption Market Share by Countries (2015-2020)

Table 48. Europe Bio Pharma Buffer Value by Countries (2015-2020) ($ Millions)

Table 49. Europe Bio Pharma Buffer Value Market Share by Countries (2015-2020)

Table 50. Europe Bio Pharma Buffer Consumption by Type (2015-2020) (kL)

Table 51. Europe Bio Pharma Buffer Consumption Market Share by Type (2015-2020)

Table 52. Europe Bio Pharma Buffer Consumption by Application (2015-2020) (kL)

Table 53. Europe Bio Pharma Buffer Consumption Market Share by Application (2015-2020)

Table 54. Middle East & Africa Bio Pharma Buffer Consumption by Countries (2015-2020) (kL)

Table 55. Middle East & Africa Bio Pharma Buffer Consumption Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Bio Pharma Buffer Value by Countries (2015-2020) ($ Millions)

Table 57. Middle East & Africa Bio Pharma Buffer Value Market Share by Countries (2015-2020)

Table 58. Middle East & Africa Bio Pharma Buffer Consumption by Type (2015-2020) (kL)

Table 59. Middle East & Africa Bio Pharma Buffer Consumption Market Share by Type (2015-2020)

Table 60. Middle East & Africa Bio Pharma Buffer Consumption by Application (2015-2020) (kL)

Table 61. Middle East & Africa Bio Pharma Buffer Consumption Market Share by Application (2015-2020)

Table 62. Bio Pharma Buffer Distributors List

Table 63. Bio Pharma Buffer Customer List

Table 64. Global Bio Pharma Buffer Consumption Forecast by Countries (2021-2025) (kL)

Table 65. Global Bio Pharma Buffer Consumption Market Forecast by Regions

Table 66. Global Bio Pharma Buffer Value Forecast by Countries (2021-2025) ($ Millions)

Table 67. Global Bio Pharma Buffer Value Market Share Forecast by Regions

Table 68. Global Bio Pharma Buffer Consumption Forecast by Type (2021-2025) (kL)

Table 69. Global Bio Pharma Buffer Consumption Market Share Forecast by Type (2021-2025)

Table 70. Global Bio Pharma Buffer Value Forecast by Type (2021-2025) ($ Millions)

Table 71. Global Bio Pharma Buffer Value Market Share Forecast by Type (2021-2025)

Table 72. Global Bio Pharma Buffer Consumption Forecast by Application (2021-2025) (kL)

Table 73. Global Bio Pharma Buffer Consumption Market Share Forecast by Application (2021-2025)

Table 74. Global Bio Pharma Buffer Value Forecast by Application (2021-2025) ($ Millions)

Table 75. Global Bio Pharma Buffer Value Market Share Forecast by Application (2021-2025)

Table 76. Avantor Product Offered

Table 77. Avantor Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 78. Avantor Main Business

Table 79. Avantor Latest Developments

Table 80. Avantor Basic Information, Company Total Revenue (in $ million), Bio Pharma Buffer Manufacturing Base, Sales Area and Its Competitors

Table 81. XZL BIO-TECHNOLOGY Product Offered

Table 82. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 83. XZL BIO-TECHNOLOGY Main Business

Table 84. XZL BIO-TECHNOLOGY Latest Developments

Table 85. XZL BIO-TECHNOLOGY Basic Information, Company Total Revenue (in $ million), Bio Pharma Buffer Manufacturing Base, Sales Area and Its Competitors

Table 86. Alfa Aesar (Thermo Fisher) Product Offered

Table 87. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 88. Alfa Aesar (Thermo Fisher) Main Business

Table 89. Alfa Aesar (Thermo Fisher) Latest Developments

Table 90. Alfa Aesar (Thermo Fisher) Basic Information, Company Total Revenue (in $ million), Bio Pharma Buffer Manufacturing Base, Sales Area and Its Competitors

Table 91. Lonza Product Offered

Table 92. Lonza Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 93. Lonza Main Business

Table 94. Lonza Latest Developments

Table 95. Lonza Basic Information, Company Total Revenue (in $ million), Bio Pharma Buffer Manufacturing Base, Sales Area and Its Competitors

Table 96. Bio-Rad Product Offered

Table 97. Bio-Rad Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 98. Bio-Rad Main Business

Table 99. Bio-Rad Latest Developments

Table 100. Bio-Rad Basic Information, Company Total Revenue (in $ million), Bio Pharma Buffer Manufacturing Base, Sales Area and Its Competitors

Table 101. Merck Product Offered

Table 102. Merck Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 103. Merck Main Business

Table 104. Merck Latest Developments

Table 105. Merck Basic Information, Company Total Revenue (in $ million), Bio Pharma Buffer Manufacturing Base, Sales Area and Its Competitors

Table 106. Promega Corporation Product Offered

Table 107. Promega Corporation Basic Information, Company Total Revenue (in $ million), Bio Pharma Buffer Manufacturing Base, Sales Area and Its Competitors

Table 108. Promega Corporation Main Business

Table 109. Promega Corporation Latest Developments

Table 110. Promega Corporation Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 111. BD Product Offered

Table 112. BD Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 113. BD Main Business

Table 114. BD Latest Developments

Table 115. BD Basic Information, Company Total Revenue (in $ million), Bio Pharma Buffer Manufacturing Base, Sales Area and Its Competitors

Table 116. Hamilton Company Product Offered

Table 117. Hamilton Company Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 118. Hamilton Company Main Business

Table 119. Hamilton Company Latest Developments

Table 120. Hamilton Company Basic Information, Company Total Revenue (in $ million), Bio Pharma Buffer Manufacturing Base, Sales Area and Its Competitors

Table 121. GE Healthcare Product Offered

Table 122. GE Healthcare Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 123. GE Healthcare Main Business

Table 124. GE Healthcare Latest Developments

Table 125. GE Healthcare Basic Information, Company Total Revenue (in $ million), Bio Pharma Buffer Manufacturing Base, Sales Area and Its Competitors

Table 126. SRL Product Offered

Table 127. SRL Bio Pharma Buffer Sales (kL), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)

Table 128. SRL Main Business

Table 129. SRL Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 130. SRL Latest Developments

List of Figures

Figure 1. Picture of Bio Pharma Buffer

Figure 2. Bio Pharma Buffer Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Bio Pharma Buffer Consumption Growth Rate 2015-2025 (kL)

Figure 5. Global Bio Pharma Buffer Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Phosphates Type

Figure 7. Product Picture of Acetates Type

Figure 8. Product Picture of TRIS Type

Figure 9. Product Picture of Others

Figure 10. Global Bio Pharma Buffer Consumption Market Share by Type (2015-2020)

Figure 11. Global Bio Pharma Buffer Value Market Share by Type (2015-2020)

Figure 12. Bio Pharma Buffer Consumed in Research Institution

Figure 13. Global Bio Pharma Buffer Market: Research Institution (2015-2020) (kL)

Figure 14. Global Bio Pharma Buffer Market: Research Institution (2015-2020) ($ Millions)

Figure 15. Bio Pharma Buffer Consumed in Pharmaceutical Industry

Figure 16. Global Bio Pharma Buffer Market: Pharmaceutical Industry (2015-2020) (kL)

Figure 17. Global Bio Pharma Buffer Market: Pharmaceutical Industry (2015-2020) ($ Millions)

Figure 18. Bio Pharma Buffer Consumed in Others

Figure 19. Global Bio Pharma Buffer Market: Others (2015-2020) (kL)

Figure 20. Global Bio Pharma Buffer Market: Others (2015-2020) ($ Millions)

Figure 21. Global Bio Pharma Buffer Consumption Market Share by Application (2015-2020)

Figure 22. Global Bio Pharma Buffer Value Market Share by Application (2015-2020)

Figure 23. Global Bio Pharma Buffer Sales Market Share by Company in 2017

Figure 24. Global Bio Pharma Buffer Sales Market Share by Company in 2019

Figure 25. Global Bio Pharma Buffer Revenue Market Share by Company in 2017

Figure 26. Global Bio Pharma Buffer Revenue Market Share by Company in 2019

Figure 27. Global Bio Pharma Buffer Sale Price by Company in 2019

Figure 28. Global Bio Pharma Buffer Consumption Market Share by Regions 2015-2020

Figure 29. Global Bio Pharma Buffer Value Market Share by Regions 2015-2020

Figure 30. Americas Bio Pharma Buffer Consumption 2015-2020 (kL)

Figure 31. Americas Bio Pharma Buffer Value 2015-2020 ($ Millions)

Figure 32. APAC Bio Pharma Buffer Consumption 2015-2020 (kL)

Figure 33. APAC Bio Pharma Buffer Value 2015-2020 ($ Millions)

Figure 34. Europe Bio Pharma Buffer Consumption 2015-2020 (kL)

Figure 35. Europe Bio Pharma Buffer Value 2015-2020 ($ Millions)

Figure 36. Middle East & Africa Bio Pharma Buffer Consumption 2015-2020 (kL)

Figure 37. Middle East & Africa Bio Pharma Buffer Value 2015-2020 ($ Millions)

Figure 38. Americas Bio Pharma Buffer Consumption Market Share by Countries in 2019

Figure 39. Americas Bio Pharma Buffer Value Market Share by Countries in 2019

Figure 40. Americas Bio Pharma Buffer Consumption Market Share by Type in 2019

Figure 41. Americas Bio Pharma Buffer Consumption Market Share by Application in 2019

Figure 42. United States Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 43. United States Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 44. Canada Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 45. Canada Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 46. Mexico Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 47. Mexico Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 48. APAC Bio Pharma Buffer Consumption Market Share by Countries in 2019

Figure 49. APAC Bio Pharma Buffer Value Market Share by Regions in 2019

Figure 50. APAC Bio Pharma Buffer Consumption Market Share by Type in 2019

Figure 51. APAC Bio Pharma Buffer Consumption Market Share by Application in 2019

Figure 52. China Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 53. China Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 54. Japan Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 55. Japan Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 56. Korea Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 57. Korea Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 58. Southeast Asia Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 59. Southeast Asia Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 60. India Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 61. India Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 62. Australia Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 63. Australia Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 64. Europe Bio Pharma Buffer Consumption Market Share by Countries in 2019

Figure 65. Europe Bio Pharma Buffer Value Market Share by Countries in 2019

Figure 66. Europe Bio Pharma Buffer Consumption Market Share by Type in 2019

Figure 67. Europe Bio Pharma Buffer Consumption Market Share by Application in 2019

Figure 68. Germany Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 69. Germany Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 70. France Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 71. France Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 72. UK Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 73. UK Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 74. Italy Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 75. Italy Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 76. Russia Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 77. Russia Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 78. Middle East & Africa Bio Pharma Buffer Consumption Market Share by Countries in 2019

Figure 79. Middle East & Africa Bio Pharma Buffer Value Market Share by Countries in 2019

Figure 80. Middle East & Africa Bio Pharma Buffer Consumption Market Share by Type in 2019

Figure 81. Middle East & Africa Bio Pharma Buffer Consumption Market Share by Application in 2019

Figure 82. Egypt Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 83. Egypt Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 84. South Africa Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 85. South Africa Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 86. Israel Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 87. Israel Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 88. Turkey Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 89. Turkey Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 90. GCC Countries Bio Pharma Buffer Consumption Growth 2015-2020 (kL)

Figure 91. GCC Countries Bio Pharma Buffer Value Growth 2015-2020 ($ Millions)

Figure 92. Global Bio Pharma Buffer Consumption Growth Rate Forecast (2021-2025) (kL)

Figure 93. Global Bio Pharma Buffer Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 94. Americas Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 95. Americas Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 96. APAC Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 97. APAC Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 98. Europe Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 99. Europe Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 100. Middle East & Africa Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 101. Middle East & Africa Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 102. United States Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 103. United States Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 104. Canada Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 105. Canada Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 106. Mexico Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 107. Mexico Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 108. Brazil Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 109. Brazil Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 110. China Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 111. China Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 112. Japan Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 113. Japan Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 114. Korea Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 115. Korea Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 116. Southeast Asia Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 117. Southeast Asia Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 118. India Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 119. India Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 120. Australia Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 121. Australia Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 122. Germany Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 123. Germany Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 124. France Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 125. France Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 126. UK Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 127. UK Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 128. Italy Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 129. Italy Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 130. Russia Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 131. Russia Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 132. Spain Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 133. Spain Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 134. Egypt Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 135. Egypt Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 136. South Africa Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 137. South Africa Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 138. Israel Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 139. Israel Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 140. Turkey Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 141. Turkey Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 142. GCC Countries Bio Pharma Buffer Consumption 2021-2025 (kL)

Figure 143. GCC Countries Bio Pharma Buffer Value 2021-2025 ($ Millions)

Figure 144. Avantor Bio Pharma Buffer Market Share (2018-2020)

Figure 145. XZL BIO-TECHNOLOGY Bio Pharma Buffer Market Share (2018-2020)

Figure 146. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Market Share (2018-2020)

Figure 147. Lonza Bio Pharma Buffer Market Share (2018-2020)

Figure 148. Bio-Rad Bio Pharma Buffer Market Share (2018-2020)

Figure 149. Merck Bio Pharma Buffer Market Share (2018-2020)

Figure 150. Promega Corporation Bio Pharma Buffer Market Share (2018-2020)

Figure 151. BD Bio Pharma Buffer Market Share (2018-2020)

Figure 152. Hamilton Company Bio Pharma Buffer Market Share (2018-2020)

Figure 153. GE Healthcare Bio Pharma Buffer Market Share (2018-2020)

Figure 154. SRL Bio Pharma Buffer Market Share (2018-2020)

Sample Request is not available